AG00GU55

935888-69-0 | ONX-0912

935888-69-0
AG00GU55
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 935888-69-0
Catalog Number AG00GU55(AGN-PC-0ONO5H)
Chemical Name ONX-0912
IUPAC Name N-[(2S)-3-methoxy-1-[[(2S)-3-methoxy-1-[[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]-2-methyl-1,3-thiazole-5-carboxamide
InChI InChI=1S/C25H32N4O7S/c1-15-26-11-20(37-15)24(33)29-19(13-35-4)23(32)28-18(12-34-3)22(31)27-17(21(30)25(2)14-36-25)10-16-8-6-5-7-9-16/h5-9,11,17-19H,10,12-14H2,1-4H3,(H,27,31)(H,28,32)(H,29,33)/t17-,18-,19-,25+/m0/s1
InChI Key SWZXEVABPLUDIO-WSZYKNRRSA-N
MDL Number MFCD25976563
Molecular Formula C25H32N4O7S
Molecular Weight 532.6092
SMILES C[C@]1(OC1)C([C@H](CC2=CC=CC=C2)NC([C@@H](NC([C@@H](NC(C3=CN=C(C)S3)=O)COC)=O)COC)=O)=O
UNII MZ37792Y8J
Synonyms
ONX 0912, oprozomib, Oprozomib, 935888-69-0, ONX-0912, ONX 0912, Oprozomib (ONX-0912), PR-047, UNII-MZ37792Y8J, MZ37792Y8J, Oprozomib (ONX 0912), N-((S)-3-methoxy-1-(((S)-3-methoxy-1-(((S)-1-((R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-yl)amino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)-2-methylthiazole-5-carboxamide, Oprozomib [USAN:INN], PR 047, oprozomib-onx-0912, Oprozomib (USAN/INN), GTPL8739, SCHEMBL1709971, CHEMBL2103884, C25H32N4O7S, EX-A332, ONX0912, SWZXEVABPLUDIO-WSZYKNRRSA-N, AOB87341, BCP07603, 2614AH, BDBM50398607, MFCD25976563, ZINC43202141, AKOS028109171, CS-2767, DB11991, QC-9273, SB16496, NCGC00345799-01, AS-17020, BC600600, HY-12113, O-Methyl-N-((2-methylthiazol-5-yl)carbonyl)-L-seryl-O-methyl-N-((1S)-1-benzyl-2-((2R)- 2-methyloxiran-2-yl)-2-oxoethyl)-L-serinamide, FT-0700414, A14181, D10318, S-7831, J-690398, L-Serinamide, O-methyl-N-((2-methyl-5-thiazolyl)carbonyl)-L-seryl-O-methyl-N-((1S)-2- ((2R)-2-methyl-2-oxiranyl)-2-oxo-1-(phenylmethyl)ethyl)-, L-Serinamide, O-methyl-N-[(2-methyl-5-thiazolyl)carbonyl]-L-seryl-O-methyl-N-[(1S)-2-[(2R)-2-methyl-, L-Serinamide, O-methyl-N-[(2-methyl-5-thiazolyl)carbonyl]-L-seryl-O-methyl-N-[(1S)-2-[(2R)-2-methyl-2-oxiranyl]-2-oxo-1-(phenylmethyl)ethyl]-, N-((S)-3-methoxy-1-((S)-3-methoxy-1-((S)-1-((R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-ylamino)-1-oxopropan-2-ylamino)-1-oxopropan-2-yl)-2-methylthiazole-5-carboxamide, N-?((S)?-?3-?methoxy-?1-?(((S)?-?3-?methoxy-?1-?(((S)?-?1-?((R)?-?2-?methyloxiran-?2-?yl)?-?1-?oxo-?3-?phenylpropan-?2-?yl)?amino)?-?1-?oxopropan-?2-?yl)?amino)?-?1-?oxopropan-?2-?yl)?-?2-?methylthiazole-?5-?carboxamide, N-[(2S)-3-methoxy-1-[[(2S)-3-methoxy-1-[[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]-2-methyl-1,3-thiazole-5-carboxamide, PR-047|||ONX-0912|||N-[(2S)-3-Methoxy-1-[[(2S)-3-methoxy-1-[[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]-2-methyl-1,3-thiazole-5-carboxamide, 1,2-Epoxyhexane, Oprozomib [USAN], D0F9BT, PR-141, PR-924, PR-928, ACN-039825, A1934, Proteasome inhibitor (oral, cancer), Proteolix Inc/Onyx Pharmaceuticals Inc, Proteasome inhibitor program (oral, cancer), Onyx Pharmaceuticals/Ono Pharmaceutical, O-Methyl-N-[(2-methyl-5-thiazolyl)carbonyl]-L-seryl-O-methyl-N-[(1S)-2-[(2R)-2-methyl-2-oxiranyl]-2-oxo-1-(phenylmethyl)ethyl]-L-serinamide,

Product Recommendations

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited